85 related articles for article (PubMed ID: 19128373)
1. Trans-vitreal endoresection for vasoproliferative retinal tumours.
Gibran SK
Clin Exp Ophthalmol; 2008 Nov; 36(8):712-6. PubMed ID: 19128373
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor and intravitreal anti-VEGF therapy with bevacizumab in vasoproliferative retinal tumors.
Saito W; Kase S; Fujiya A; Dong Z; Noda K; Ishida S
Retina; 2013 Oct; 33(9):1959-67. PubMed ID: 23652580
[TBL] [Abstract][Full Text] [Related]
3. Vasoproliferative retinal tumours in a Swedish population.
Makdoumi K; Crafoord S
Acta Ophthalmol; 2011 Feb; 89(1):91-4. PubMed ID: 19860770
[TBL] [Abstract][Full Text] [Related]
4. The surgical management of vasoproliferative tumours.
Smith J; Steel D
Ophthalmologica; 2011; 226 Suppl 1():42-5. PubMed ID: 21778779
[TBL] [Abstract][Full Text] [Related]
5. Update on the management of vasoproliferative tumour.
Temblador-Barba I; Delgado-Alonso EM; Toribio-García M; Martínez-Campillo L; Molina-Leyva I; Martínez-Jiménez M
Arch Soc Esp Oftalmol (Engl Ed); 2018 Jul; 93(7):350-353. PubMed ID: 29459169
[TBL] [Abstract][Full Text] [Related]
6. Management of Vision-Threatening Complications of Vasoproliferative Tumors of the Retina.
Garcia-Arumi J; Distefano LN; Fonollosa A; Quijano C; Corcostegui B
Ophthalmic Res; 2015; 54(1):34-40. PubMed ID: 26065358
[TBL] [Abstract][Full Text] [Related]
7. [Spontaneous peeling of the epimacular membrane after cryotherapy of retinal vasoproliferative tumors: report of a case].
Coulier J; Gribomont AC; De Potter P
Bull Soc Belge Ophtalmol; 2013; (322):49-54. PubMed ID: 24923082
[TBL] [Abstract][Full Text] [Related]
8. Vasoproliferative tumours of the retina.
Heimann H; Bornfeld N; Vij O; Coupland SE; Bechrakis NE; Kellner U; Foerster MH
Br J Ophthalmol; 2000 Oct; 84(10):1162-9. PubMed ID: 11004104
[TBL] [Abstract][Full Text] [Related]
9. Three-year safety and visual acuity results of epimacular 90 strontium/90 yttrium brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.
Avila MP; Farah ME; Santos A; Carla L; Fuji G; Rossi J; Nau J
Retina; 2012 Jan; 32(1):10-8. PubMed ID: 21817963
[TBL] [Abstract][Full Text] [Related]
10. [Effectivity and safety of bevacizumab intravitreal injections for exudative age-related macular degeneration treatment--6 months observations].
Małgorzata F
Klin Oczna; 2010; 112(7-9):213-6. PubMed ID: 21121123
[TBL] [Abstract][Full Text] [Related]
11. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
[TBL] [Abstract][Full Text] [Related]
12. Retinal vasoproliferative tumors in 6 patients with neurofibromatosis type 1.
Shields JA; Pellegrini M; Kaliki S; Mashayekhi A; Shields CL
JAMA Ophthalmol; 2014 Feb; 132(2):190-6. PubMed ID: 24357334
[TBL] [Abstract][Full Text] [Related]
13. Laser and ranibuzumab combination for retinal vasoproliferative tumor's management.
Fernández-Martínez C; Martínez-Toldos JJ; Hernández-Artola F
Arch Soc Esp Oftalmol; 2015 Dec; 90(12):593-6. PubMed ID: 26347320
[TBL] [Abstract][Full Text] [Related]
14. Treatment of serous macular detachment associated with circumscribed choroidal hemangioma.
Kwon HJ; Kim M; Lee CS; Lee SC
Am J Ophthalmol; 2012 Jul; 154(1):137-145.e1. PubMed ID: 22465363
[TBL] [Abstract][Full Text] [Related]
15. Treatment of radiation maculopathy with intravitreal injection of bevacizumab (Avastin).
Gupta A; Muecke JS
Retina; 2008; 28(7):964-8. PubMed ID: 18698298
[TBL] [Abstract][Full Text] [Related]
16. Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for exudative age-related macular degeneration.
Lee SJ; Koh HJ
Ophthalmology; 2011 Jan; 118(1):101-10. PubMed ID: 20678805
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
Ramasubramanian A; Shields CL
Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215
[TBL] [Abstract][Full Text] [Related]
18. Combined intravitreal bevacizumab and triamcinolone in exudative age-related macular degeneration.
Jonas JB; Libondi T; Golubkina L; Spandau UH; Schlichtenbrede F; Rensch F
Acta Ophthalmol; 2010 Sep; 88(6):630-4. PubMed ID: 19432871
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone and bevacizumab combination therapy for refractory choroidal neovascularization with retinal angiomatous proliferation.
Bakri SJ; Ekdawi NS
Eye (Lond); 2008 Jul; 22(7):978-80. PubMed ID: 18034193
[No Abstract] [Full Text] [Related]
20. Retinal vasoproliferative tumor (Retinal reactive astrocytic tumor).
Crespo Carballés MJ; Sastre-Ibáñez M; Prieto Del Cura M; Jimeno Anaya L; Pastora N; Quijada Angeli S
J Fr Ophtalmol; 2019 Dec; 42(10):e455-e458. PubMed ID: 31296349
[No Abstract] [Full Text] [Related]
[Next] [New Search]
